---
title: "Endoscopic Ultrasound-guided Fine Needle Aspiration of Solid Masses: Histological and Immunohistochemical Evaluation"
nct_id: NCT01437410
overall_status: COMPLETED
sponsor: Samsung Medical Center
study_type: OBSERVATIONAL
primary_condition: Pancreatic Mass
countries: South Korea
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01437410.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01437410"
ct_last_update_post_date: 2011-09-20
last_seen_at: "2026-05-12T06:07:54.185Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Endoscopic Ultrasound-guided Fine Needle Aspiration of Solid Masses: Histological and Immunohistochemical Evaluation

**NCT ID:** [NCT01437410](https://clinicaltrials.gov/study/NCT01437410)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 116
- **Lead Sponsor:** Samsung Medical Center
- **Conditions:** Pancreatic Mass, Peripancreatic Mass
- **Start Date:** 2009-01
- **CT.gov Last Update:** 2011-09-20

## Brief Summary

The aim of this retrospective single center study was to evaluate the clinical utility of histological and immunohistochemical analyses of specimens obtained by endoscopic ultrasound-guided fine needle aspiration (EUS-FNA).

## Eligibility

- **Minimum age:** 30 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* We retrospectively reviewed medical records of patients who underwent EUS-FNA to evaluate solid pancreatic or peripancreatic lesions from January 2009 to July 2010

Exclusion Criteria:

* Patients with unavailable data
```

## Arms

- **EUS-FNA**

## Interventions

- **EUS-FNA** (PROCEDURE) — tissue samples were harvested from 116 patients undergoing EUS-FNA of solid masses for cytologic smear and histological analysis.

## Primary Outcomes

- **the diagnostic accuracy of cytology, histology, and combined analysis of specimens obtained by EUS-FNA for pancreatic or peripancreatic solid masses** _(time frame: at least 6 months after surgery or clinical follow up)_ — The first, pre-op checked each diagnostic accuracy of cytology, histology, and combined analysis by EUS-FNA. and then, finaly diagnosis following surgery or clinical follow up for at least 6 months was re-check with diagnosic accuracy of cytology, histology, and combined analysis pre-diagnosed by EUS-FNA

## Locations (1)

- Samsung Medical Center, Seoul, South Korea

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.samsung medical center|seoul||south korea` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01437410.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01437410*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*